vs
DBV Technologies S.A.(DBVT)与Xos, Inc.(XOS)财务数据对比。点击上方公司名可切换其他公司
Xos, Inc.的季度营收约是DBV Technologies S.A.的1.9倍($5.2M vs $2.8M),Xos, Inc.净利率更高(-186.8% vs -1195.5%,领先1008.7%),DBV Technologies S.A.同比增速更快(158.8% vs -54.5%),过去两年DBV Technologies S.A.的营收复合增速更高(12.4% vs -35.7%)
DBV Technologies是一家总部位于法国巴涅的公开上市生物制药企业,核心研发成果为Viaskin给药技术,可在不进入血液循环的前提下,让过敏原或抗原作用于完整皮肤。其花生过敏疗法Viaskin Peanut的临床开发,已获得美国食品药品监督管理局授予快速通道资格。
Xos, Inc.是一家美国制造商,专注于生产商用电动车辆以及移动式电动汽车充电桩。该公司扎根商用车电动化领域,为物流、货运等商业运输场景提供纯电动力解决方案与配套充电设备,助力商用车领域的低碳转型。
DBVT vs XOS — 直观对比
营收规模更大
XOS
是对方的1.9倍
$2.8M
营收增速更快
DBVT
高出213.3%
-54.5%
净利率更高
XOS
高出1008.7%
-1195.5%
两年增速更快
DBVT
近两年复合增速
-35.7%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $2.8M | $5.2M |
| 净利润 | $-33.2M | $-9.8M |
| 毛利率 | — | -50.5% |
| 营业利润率 | -1235.7% | -186.6% |
| 净利率 | -1195.5% | -186.8% |
| 营收同比 | 158.8% | -54.5% |
| 净利润同比 | -8.9% | 48.6% |
| 每股收益(稀释后) | $-0.24 | $-0.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DBVT
XOS
| Q4 25 | — | $5.2M | ||
| Q3 25 | $2.8M | $16.5M | ||
| Q2 25 | $1.5M | $18.4M | ||
| Q1 25 | — | $5.9M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | — | $15.8M | ||
| Q2 24 | $1.2M | $15.5M | ||
| Q1 24 | $1.4M | $12.6M |
净利润
DBVT
XOS
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $-33.2M | $2.1M | ||
| Q2 25 | $-41.9M | $-7.5M | ||
| Q1 25 | — | $-10.2M | ||
| Q4 24 | — | $-19.0M | ||
| Q3 24 | — | $-10.5M | ||
| Q2 24 | $-33.1M | $-9.7M | ||
| Q1 24 | $-27.3M | $-11.0M |
毛利率
DBVT
XOS
| Q4 25 | — | -50.5% | ||
| Q3 25 | — | 15.3% | ||
| Q2 25 | — | 8.8% | ||
| Q1 25 | — | 20.6% | ||
| Q4 24 | — | -32.4% | ||
| Q3 24 | — | 18.1% | ||
| Q2 24 | — | 13.1% | ||
| Q1 24 | — | 22.1% |
营业利润率
DBVT
XOS
| Q4 25 | — | -186.6% | ||
| Q3 25 | -1235.7% | -42.4% | ||
| Q2 25 | -2806.2% | -38.5% | ||
| Q1 25 | — | -157.7% | ||
| Q4 24 | — | -127.0% | ||
| Q3 24 | — | -61.4% | ||
| Q2 24 | -2914.9% | -73.2% | ||
| Q1 24 | -2029.7% | -81.1% |
净利率
DBVT
XOS
| Q4 25 | — | -186.8% | ||
| Q3 25 | -1195.5% | 12.9% | ||
| Q2 25 | -2858.4% | -40.8% | ||
| Q1 25 | — | -173.3% | ||
| Q4 24 | — | -165.4% | ||
| Q3 24 | — | -66.6% | ||
| Q2 24 | -2852.4% | -62.2% | ||
| Q1 24 | -1943.5% | -87.1% |
每股收益(稀释后)
DBVT
XOS
| Q4 25 | — | $-0.76 | ||
| Q3 25 | $-0.24 | $0.22 | ||
| Q2 25 | $-0.31 | $-0.91 | ||
| Q1 25 | — | $-1.26 | ||
| Q4 24 | — | $-2.34 | ||
| Q3 24 | — | $-1.32 | ||
| Q2 24 | $-0.34 | $-1.23 | ||
| Q1 24 | $-0.28 | $-1.80 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $69.8M | $14.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $52.9M | $23.3M |
| 总资产 | $110.5M | $60.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
DBVT
XOS
| Q4 25 | — | $14.0M | ||
| Q3 25 | $69.8M | $14.1M | ||
| Q2 25 | $103.2M | $8.8M | ||
| Q1 25 | — | $4.8M | ||
| Q4 24 | — | $11.0M | ||
| Q3 24 | — | $8.4M | ||
| Q2 24 | $66.2M | $19.7M | ||
| Q1 24 | $101.5M | $46.2M |
股东权益
DBVT
XOS
| Q4 25 | — | $23.3M | ||
| Q3 25 | $52.9M | $31.1M | ||
| Q2 25 | $86.2M | $18.3M | ||
| Q1 25 | — | $24.8M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | $79.1M | $59.2M | ||
| Q1 24 | $111.7M | $67.8M |
总资产
DBVT
XOS
| Q4 25 | — | $60.4M | ||
| Q3 25 | $110.5M | $73.8M | ||
| Q2 25 | $143.4M | $80.3M | ||
| Q1 25 | — | $87.7M | ||
| Q4 24 | — | $98.3M | ||
| Q3 24 | — | $120.5M | ||
| Q2 24 | $114.2M | $123.4M | ||
| Q1 24 | $145.9M | $135.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-32.4M | $2.4M |
| 自由现金流经营现金流 - 资本支出 | $-32.6M | — |
| 自由现金流率自由现金流/营收 | -1173.5% | — |
| 资本支出强度资本支出/营收 | 4.2% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-138.3M | — |
8季度趋势,按日历期对齐
经营现金流
DBVT
XOS
| Q4 25 | — | $2.4M | ||
| Q3 25 | $-32.4M | $3.1M | ||
| Q2 25 | $-33.9M | $4.6M | ||
| Q1 25 | — | $-4.8M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $-11.5M | ||
| Q2 24 | $-35.1M | $-26.0M | ||
| Q1 24 | $-34.7M | $-14.6M |
自由现金流
DBVT
XOS
| Q4 25 | — | — | ||
| Q3 25 | $-32.6M | — | ||
| Q2 25 | $-33.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-11.7M | ||
| Q2 24 | $-35.8M | $-26.1M | ||
| Q1 24 | $-36.0M | $-14.6M |
自由现金流率
DBVT
XOS
| Q4 25 | — | — | ||
| Q3 25 | -1173.5% | — | ||
| Q2 25 | -2316.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -73.9% | ||
| Q2 24 | -3084.0% | -168.1% | ||
| Q1 24 | -2560.6% | -115.7% |
资本支出强度
DBVT
XOS
| Q4 25 | — | 0.0% | ||
| Q3 25 | 4.2% | 0.0% | ||
| Q2 25 | 2.2% | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | 63.0% | 0.8% | ||
| Q1 24 | 94.9% | 0.2% |
现金转化率
DBVT
XOS
| Q4 25 | — | — | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图